Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Rang in aandelen #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Aandeelprijs
$0.83030862
Laatst gesynchroniseerd: 2024-06-27
Marktkapitalisatie
$726.64K
Verandering (1 dag)
-1.35%
Verandering (1 jaar)
0.00%
Land
DE
Handel Epigenomics AG (ECX)

Categorie

Koersgeschiedenis voor Epigenomics AG (ECX)
Hoogste slotkoers: $1.42 op 2024-06-01

Laagste slotkoers: $761.72 op 2014-09-01
Koersgeschiedenis van Epigenomics AG van 2014 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2024 -40.31%
2023 -70.25%
2022 -39.44%
2021 -83.30%
2020 -68.68%
2019 -24.83%
2018 -54.25%
2017 -3.39%
2016 90.76%
2015 -58.46%
2014 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$592.13 22.08%
US
$203.44 -3.23%
US
$23.08 67.91%
CN
$310.78 96.15%
US
$560.26 -14.33%
US